ProPhase Labs, Inc. Depreciation
ProPhase Labs, Inc. (PRPH) reported Depreciation of $2.20 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-06-01.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-06-01
- ProPhase Labs, Inc. depreciation for the quarter ending 2025-12-31 was $300.00K, a 25.00% decline year-over-year.
- ProPhase Labs, Inc. depreciation for the quarter ending 2025-09-30 was $400.00K, a 78.95% decline year-over-year.
- ProPhase Labs, Inc. depreciation for the quarter ending 2025-06-30 was $700.00K, a 22.22% decline year-over-year.
- ProPhase Labs, Inc. depreciation for the quarter ending 2024-12-31 was $400.00K.
- ProPhase Labs, Inc. depreciation for fiscal 2025 was $2.20M, a 47.62% decline from fiscal 2024.
- ProPhase Labs, Inc. depreciation for fiscal 2024 was $4.20M, a 35.48% increase from fiscal 2023.
- ProPhase Labs, Inc. depreciation for fiscal 2023 was $3.10M, a 34.78% increase from fiscal 2022.
- ProPhase Labs, Inc. depreciation for fiscal 2022 was $2.30M, a 21.05% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-01 | $700.00K derived: sum of 2 quarters · filed 2026-06-01 | $1.40M derived: sum of 3 quarters · filed 2026-06-01 | $2.20M 10-K · filed 2026-06-01 | |
| 2025-09-30 | $400.00K 10-Q · filed 2025-11-19 | $1.10M derived: sum of 2 quarters · filed 2025-11-19 | $1.90M 10-Q · filed 2025-11-19 | ||
| 2025-06-30 | $700.00K 10-Q · filed 2025-08-13 | $1.50M 10-Q · filed 2025-08-13 | |||
| 2024-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-01 | $2.30M derived: sum of 2 quarters · filed 2026-06-01 | $3.20M derived: sum of 3 quarters · filed 2026-06-01 | $4.20M 10-K · filed 2026-06-01 | |
| 2024-09-30 | $1.90M 10-Q · filed 2025-11-19 | $2.80M derived: sum of 2 quarters · filed 2025-11-19 | $3.80M 10-Q · filed 2025-11-19 | ||
| 2024-06-30 | $900.00K 10-Q · filed 2025-08-13 | $1.80M 10-Q · filed 2025-08-13 | |||
| 2023-12-31 | $3.10M 10-K · filed 2025-04-01 | ||||
| 2022-12-31 | $663.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $1.20M derived: sum of 2 quarters · filed 2024-03-29 | $1.81M derived: sum of 3 quarters · filed 2024-03-29 | $2.30M 10-K · filed 2024-03-29 | |
| 2022-09-30 | $540.00K 10-Q · filed 2022-11-10 | $1.15M derived: sum of 2 quarters · filed 2022-11-10 | $1.64M 10-Q · filed 2022-11-10 | $2.16M derived: sum of 4 quarters · filed 2023-03-29 | |
| 2022-06-30 | $607.00K 10-Q · filed 2022-08-12 | $1.10M 10-Q · filed 2022-08-12 | $1.62M derived: sum of 3 quarters · filed 2023-03-29 | $2.10M derived: sum of 4 quarters · filed 2023-03-29 | |
| 2022-03-31 | $491.00K 10-Q · filed 2022-05-13 | $1.01M derived: sum of 2 quarters · filed 2023-03-29 | $1.49M derived: sum of 3 quarters · filed 2023-03-29 | $1.97M derived: sum of 4 quarters · filed 2023-03-29 | |
| 2021-12-31 | $519.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $1.00M derived: sum of 2 quarters · filed 2023-03-29 | $1.47M derived: sum of 3 quarters · filed 2023-03-29 | $1.90M 10-K · filed 2023-03-29 | $1.86M 10-K · filed 2022-03-31 |
| 2021-09-30 | $481.00K 10-Q · filed 2022-11-10 | $955.00K derived: sum of 2 quarters · filed 2022-11-10 | $1.38M 10-Q · filed 2022-11-10 | $1.50M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | $474.00K 10-Q · filed 2022-08-12 | $900.00K 10-Q · filed 2022-08-12 | $1.02M derived: sum of 3 quarters · filed 2022-08-12 | $1.11M derived: sum of 4 quarters · filed 2022-08-12 | |
| 2021-03-31 | $428.00K 10-Q · filed 2022-05-13 | $550.00K derived: sum of 2 quarters · filed 2022-05-13 | $636.00K derived: sum of 3 quarters · filed 2022-05-13 | $1.54M derived: sum of 4 quarters · filed 2022-05-13 | |
| 2020-12-31 | $122.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $208.00K derived: sum of 2 quarters · filed 2022-03-31 | $1.11M derived: sum of 3 quarters · filed 2022-03-31 | $375.00K 10-K · filed 2022-03-31 | $449.00K 10-K · filed 2021-03-31 |
| 2020-09-30 | $86.00K 10-Q · filed 2021-11-12 | $986.00K derived: sum of 2 quarters · filed 2021-11-12 | $253.00K 10-Q · filed 2021-11-12 | $848.00K derived: sum of 4 quarters · filed 2021-11-12 | |
| 2020-06-30 | $900.00K 10-Q · filed 2021-08-13 | $167.00K 10-Q · filed 2021-08-13 | $762.00K derived: sum of 3 quarters · filed 2021-08-13 | $862.00K derived: sum of 4 quarters · filed 2021-08-13 | |
| 2020-03-31 | $82.00K 10-Q · filed 2021-05-14 | -$138.00K derived: sum of 2 quarters · filed 2021-05-14 | -$38.00K derived: sum of 3 quarters · filed 2021-05-14 | $63.00K derived: sum of 4 quarters · filed 2021-05-14 | |
| 2019-12-31 | -$220.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | -$120.00K derived: sum of 2 quarters · filed 2021-03-31 | -$19.00K derived: sum of 3 quarters · filed 2021-03-31 | $82.00K 10-K · filed 2021-03-31 | $398.00K 10-K · filed 2020-03-26 |
| 2019-09-30 | $100.00K 10-Q · filed 2019-11-12 | $201.00K derived: sum of 2 quarters · filed 2019-11-12 | $302.00K 10-Q · filed 2019-11-12 | $398.00K derived: sum of 4 quarters · filed 2020-05-12 | |
| 2019-06-30 | $101.00K 10-Q · filed 2019-08-12 | $202.00K 10-Q · filed 2019-08-12 | $298.00K derived: sum of 3 quarters · filed 2020-05-12 | $395.00K derived: sum of 4 quarters · filed 2020-05-12 | |
| 2019-03-31 | $101.00K 10-Q · filed 2020-05-12 | $197.00K derived: sum of 2 quarters · filed 2020-05-12 | $294.00K derived: sum of 3 quarters · filed 2020-05-12 | $389.00K derived: sum of 4 quarters · filed 2020-05-12 | |
| 2018-12-31 | $96.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $193.00K derived: sum of 2 quarters · filed 2020-03-26 | $288.00K derived: sum of 3 quarters · filed 2020-03-26 | $383.00K 10-K · filed 2020-03-26 | |
| 2018-09-30 | $97.00K 10-Q · filed 2019-11-12 | $192.00K derived: sum of 2 quarters · filed 2019-11-12 | $287.00K 10-Q · filed 2019-11-12 | $109.00K derived: sum of 4 quarters · filed 2019-11-12 | |
| 2018-06-30 | $95.00K 10-Q · filed 2019-08-12 | $190.00K 10-Q · filed 2019-08-12 | $12.00K derived: sum of 3 quarters · filed 2019-08-12 | ||
| 2018-03-31 | $95.00K 10-Q · filed 2019-05-14 | -$83.00K derived: sum of 2 quarters · filed 2019-05-14 | |||
| 2017-12-31 | -$178.00K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2018-08-20 | $337.00K 10-K/A · filed 2018-08-20 | |||
| 2017-09-30 | $515.00K 10-Q/A · filed 2018-08-20 | ||||
| 2016-12-31 | $109.00K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2018-08-20 | $426.00K 10-K/A · filed 2018-08-20 | |||
| 2016-09-30 | $317.00K 10-Q/A · filed 2018-08-20 | ||||
| 2015-12-31 | $367.00K 10-K/A · filed 2018-08-20 | ||||
| 2015-03-31 | $83.00K 10-Q · filed 2015-05-13 | ||||
| 2014-12-31 | $277.00K 10-K · filed 2017-02-24 | ||||
| 2014-03-31 | $64.00K 10-Q · filed 2015-05-13 | ||||
| 2013-12-31 | $243.00K 10-K · filed 2016-03-29 | ||||
| 2012-12-31 | $252.00K 10-K · filed 2015-03-27 | ||||
| 2011-12-31 | $355.00K 10-K · filed 2014-03-27 | ||||
| 2010-12-31 | $363.00K 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |